Wundern Sie sich eigentlich? Wir wundern uns. Das meldet Reuters: “BERLIN, June 24 (Reuters) – The launch of German drugmaker BioNTech’s (22UAy.DE) vaccine adapted to the Omicron coronavirus variant may be delayed due to a disagreement with the regulator over the approval process, the Welt Am Sonntag (WAS) newspaper reported on Saturday. The regulator should still […]Profit frisst Gewissen oder: Trotz Rückgang des Impf-Enthusiasmus: Meldungen zu Nebenwirkungen steigen weiter: 3.917.924 – darunter 22.780 Todesmeldungen
Wundern Sie sich eigentlich? Wir wundern uns. Das meldet Reuters: “BERLIN, June 24 (Reuters) – The launch of German drugmaker BioNTech’s (22UAy.DE) vaccine adapted to the Omicron coronavirus variant may be delayed due to a disagreement with the regulator over the approval process, the Welt Am Sonntag (WAS) newspaper reported on Saturday. The regulator should still […]